Avaí Bio, Inc. (AVAI)
OTCMKTS · Delayed Price · Currency is USD
0.1220
-0.0030 (-2.40%)
Aug 17, 2026, 11:13 AM EST
Avaí Bio Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 0.08 | 0.02 | 0.08 | 0 | 0.11 | 0.03 |
Cash & Short-Term Investments | 0.08 | 0.02 | 0.08 | 0 | 0.11 | 0.03 |
Cash Growth | 730.71% | -71.45% | 28744.48% | -99.74% | 222.84% | -44.85% |
Accounts Receivable | - | - | - | - | - | 0 |
Receivables | 0.06 | 0.06 | - | - | - | 0.17 |
Prepaid Expenses | 0.01 | 0.01 | 0.01 | 0.12 | 0 | 0.13 |
Total Current Assets | 0.15 | 0.09 | 0.09 | 0.12 | 0.11 | 0.33 |
Property, Plant & Equipment | - | - | - | - | 0 | 0 |
Other Intangible Assets | 0.16 | 0.11 | 0.13 | 0.21 | 0.13 | 0.12 |
Other Long-Term Assets | 0.48 | 0.38 | - | - | - | - |
Total Assets | 0.79 | 0.57 | 0.22 | 0.32 | 0.24 | 0.45 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 1.73 | 1.59 | 0.89 | 1.08 | 0.24 | 0 |
Accrued Expenses | - | - | - | - | - | 0.19 |
Short-Term Debt | 2.28 | 1.79 | 0.9 | 0.71 | 0.64 | 0.6 |
Other Current Liabilities | - | - | - | - | - | 0.06 |
Total Current Liabilities | 4.01 | 3.39 | 1.79 | 1.79 | 0.87 | 0.86 |
Total Liabilities | 4.01 | 3.39 | 1.79 | 1.79 | 0.87 | 0.86 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 0.15 | 0.15 | 0.14 | 0.12 | 0.04 | 0.03 |
Additional Paid-In Capital | 3.02 | 2.87 | 2.39 | 1.37 | 0.17 | 0.06 |
Retained Earnings | -6.42 | -5.87 | -4.12 | -2.98 | -0.85 | -0.5 |
Comprehensive Income & Other | - | - | - | - | - | -0 |
Total Common Equity | -3.25 | -2.84 | -1.59 | -1.49 | -0.64 | -0.41 |
Shareholders' Equity | -3.22 | -2.82 | -1.56 | -1.47 | -0.63 | -0.41 |
Total Liabilities & Equity | 0.79 | 0.57 | 0.22 | 0.32 | 0.24 | 0.45 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 2.28 | 1.79 | 0.9 | 0.71 | 0.64 | 0.6 |
Net Cash (Debt) | -2.2 | -1.77 | -0.82 | -0.71 | -0.53 | -0.57 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
Filing Date Shares Outstanding | 153.92 | 153.92 | 137.51 | 117.02 | 64.5 | 26.32 |
Total Common Shares Outstanding | 153.92 | 153.21 | 137.36 | 117.17 | 38.5 | 26.32 |
Working Capital | -3.86 | -3.3 | -1.7 | -1.67 | -0.77 | -0.53 |
Book Value Per Share | -0.02 | -0.02 | -0.01 | -0.01 | -0.02 | -0.02 |
Tangible Book Value | -3.41 | -2.95 | -1.72 | -1.7 | -0.77 | -0.53 |
Tangible Book Value Per Share | -0.02 | -0.02 | -0.01 | -0.01 | -0.02 | -0.02 |
Machinery | - | - | - | - | 0 | 0 |